FibroBiologics (FBLG) Competitors $1.75 -0.16 (-8.38%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends FBLG vs. NGNE, OLMA, ATYR, RZLT, AVIR, CMPX, CGC, ACIU, CADL, and CCCCShould you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include Neurogene (NGNE), Olema Pharmaceuticals (OLMA), Atyr PHARMA (ATYR), Rezolute (RZLT), Atea Pharmaceuticals (AVIR), Compass Therapeutics (CMPX), Canopy Growth (CGC), AC Immune (ACIU), Candel Therapeutics (CADL), and C4 Therapeutics (CCCC). These companies are all part of the "pharmaceutical products" industry. FibroBiologics vs. Neurogene Olema Pharmaceuticals Atyr PHARMA Rezolute Atea Pharmaceuticals Compass Therapeutics Canopy Growth AC Immune Candel Therapeutics C4 Therapeutics FibroBiologics (NASDAQ:FBLG) and Neurogene (NASDAQ:NGNE) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, community ranking, risk, earnings and dividends. Do insiders & institutionals have more ownership in FBLG or NGNE? 52.4% of Neurogene shares are owned by institutional investors. 20.8% of FibroBiologics shares are owned by insiders. Comparatively, 9.9% of Neurogene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, FBLG or NGNE? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFibroBiologicsN/AN/A-$16.49MN/AN/ANeurogeneN/AN/A-$36.32MN/AN/A Does the media favor FBLG or NGNE? In the previous week, FibroBiologics' average media sentiment score of 0.00 equaled Neurogene'saverage media sentiment score. Company Overall Sentiment FibroBiologics Neutral Neurogene Neutral Does the MarketBeat Community favor FBLG or NGNE? Neurogene received 19 more outperform votes than FibroBiologics when rated by MarketBeat users. CompanyUnderperformOutperformFibroBiologicsOutperform Votes7100.00% Underperform VotesNo VotesNeurogeneOutperform Votes26100.00% Underperform VotesNo Votes Is FBLG or NGNE more profitable? FibroBiologics' return on equity of 0.00% beat Neurogene's return on equity.Company Net Margins Return on Equity Return on Assets FibroBiologicsN/A N/A -225.34% Neurogene N/A -32.81%-27.96% Do analysts prefer FBLG or NGNE? FibroBiologics presently has a consensus price target of $13.00, suggesting a potential upside of 642.86%. Neurogene has a consensus price target of $60.83, suggesting a potential upside of 266.47%. Given FibroBiologics' stronger consensus rating and higher possible upside, research analysts clearly believe FibroBiologics is more favorable than Neurogene.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Neurogene 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 SummaryFibroBiologics beats Neurogene on 5 of the 9 factors compared between the two stocks. Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBLG vs. The Competition Export to ExcelMetricFibroBiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$61.41M$6.23B$5.21B$9.15BDividend YieldN/A2.94%5.13%4.03%P/E RatioN/A9.4687.9017.36Price / SalesN/A310.131,245.5478.03Price / CashN/A61.4443.7535.97Price / Book43.756.055.314.79Net Income-$16.49M$154.90M$122.62M$225.00M7 Day Performance-12.50%-0.32%0.58%2.62%1 Month Performance-22.22%0.43%2.54%3.81%1 Year PerformanceN/A3.08%25.49%20.10% FibroBiologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBLGFibroBiologics1.8993 of 5 stars$1.75-8.4%$13.00+642.9%N/A$61.41MN/A0.0010Gap UpNGNENeurogene2.7267 of 5 stars$18.81-3.9%$60.83+223.4%-44.8%$279.42M$925,000.000.0090OLMAOlema Pharmaceuticals2.6548 of 5 stars$4.84-4.0%$27.00+457.9%-49.8%$277.32MN/A-2.2170News CoveragePositive NewsATYRAtyr PHARMA2.905 of 5 stars$3.29-6.8%$19.25+485.1%N/A$276.17M$235,000.00-3.5053Positive NewsRZLTRezolute3.5503 of 5 stars$4.75-3.1%$24.13+407.9%+387.0%$275.23MN/A-3.7440AVIRAtea Pharmaceuticals3.8745 of 5 stars$3.20-2.1%$6.88+115.0%-5.6%$270.28M$351.37M-1.5570Short Interest ↓Gap UpCMPXCompass Therapeutics3.1608 of 5 stars$1.95+10.2%$11.80+505.1%+87.1%$268.30M$850,000.00-5.2720Short Interest ↑News CoverageCGCCanopy Growth3.2077 of 5 stars$2.39-2.4%$3.50+46.4%-50.1%$260.37M$280.50M-0.483,150ACIUAC Immune2.2387 of 5 stars$2.61-4.0%$12.00+359.8%-35.4%$258.23M$40.97M-5.67140Positive NewsCADLCandel Therapeutics3.5492 of 5 stars$7.77-5.0%$19.00+144.5%+416.3%$252.34M$120,000.00-4.4960Insider TradeCCCCC4 Therapeutics2.0819 of 5 stars$3.50-4.6%$10.67+204.8%-33.3%$247.06M$33.67M-2.06150Positive NewsGap Down Related Companies and Tools Related Companies NGNE Competitors OLMA Competitors ATYR Competitors RZLT Competitors AVIR Competitors CMPX Competitors CGC Competitors ACIU Competitors CADL Competitors CCCC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FBLG) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
